Extreme Networks (EXTR) closed the last trading session at $14.01, gaining 26.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $18.75 indicates a 33.8% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $3.31. While the lowest estimate of $15 indicates a 7.1% increase from the current price level, the most optimistic analyst exp ...

Shares of Constellium (CSTM) have gained 38.2% over the past four weeks to close the last trading session at $11.04, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $16.60 indicates a potential upside of 50.4%.The average comprises five short-term price targets ranging from a low of $12 to a high of $24, with a standard deviation of $4.77. While the lowest estimate indicates an ...

Shares of Align Technology (ALGN) have gained 15.8% over the past four weeks to close the last trading session at $177.61, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $233.42 indicates a potential upside of 31.4%.The average comprises 12 short-term price targets ranging from a low of $170 to a high of $275, with a standard deviation of $31.09. While the lowest estimate indic ...

Shares of American Well Corporation (AMWL) have gained 11.8% over the past four weeks to close the last trading session at $7.31, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $10.71 indicates a potential upside of 46.5%.The mean estimate comprises seven short-term price targets with a standard deviation of $2.58. While the lowest estimate of $7.50 indicates a 2.6% increase fr ...

Summit Therapeutics PLC (SMMT) closed the last trading session at $28.02, gaining 61.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $37.38 indicates a 33.4% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $5.71. While the lowest estimate of $30 indicates a 7.1% increase from the current price level, the most optimistic an ...

BlackSky Technology Inc. (BKSY) will report its first-quarter 2025 results on May 8, before the bell.BKSY’s earnings surprise history has not been impressive. Its earnings lagged the Zacks Consensus Estimate in three of the trailing four quarters and beat once, with an average negative surprise of 12.9%.Factors to Note Ahead of BKSY’s Q1 ResultsFor the upcoming report, the Zacks Consensus Estimate for revenues is pegged at $27.5 million, implying a 13.6% year-over-year increase. This anticipated growth is l ...

Franklin Resources, Inc. (BEN) reported its preliminary assets under management (AUM) of $1.53 trillion as of April 30, 2025, which decreased marginally from the prior month.The decline in the AUM balance was due to the impact of preliminary long-term net outflows of $10 billion, inclusive of $10 billion of long-term net outflows at Western Asset Management, partially offset by the positive impact of foreign exchange.Breakdown of BEN’s AUM Based on Asset ClassFranklin recorded equity assets of $597.3 billio ...

HSBC Holdings (HSBC) reported first-quarter 2025 results last week. Results benefited from higher adjusted revenues and relatively stable operating expenses. On the other hand, heightened uncertainty and weakness in the economic outlook owing to geopolitical tensions and higher trade tariffs led to a rise in expected credit losses and other credit impairment charges (ECL).So now the question is, should investors think of buying HSBC stock at the moment? Let’s address this question by evaluating the company’ ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 6th:MAIA Biotechnology, Inc. (MAIA) : This immuno-oncology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.4% over the last 60 days.MAIA’s shares gained 0.5% over the last three months compared with the S&P 500’s decline of 5.6%. The company possesses a Momentum Score  of A.Byrna Technologies Inc. (BYRN) : This non-lethal defense tech ...

For the quarter ended March 2025, Expeditors International (EXPD) reported revenue of $2.67 billion, up 20.8% over the same period last year. EPS came in at $1.47, compared to $1.17 in the year-ago quarter.The reported revenue represents a surprise of +9.95% over the Zacks Consensus Estimate of $2.43 billion. With the consensus EPS estimate being $1.30, the EPS surprise was +13.08%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wal ...